levothyroxine and semaglutide What You Need To Know About & Ozempic For PCOS GLP-1 Interactions - Endocrinology Advisor

Our client was injured in a pedestrian accident when they were struck by a car

Faucibus pulvinar elementum integer enim neque volutpat

The scarcity of randomized controlled trials (RCTs) directly comparing subcutaneous tirzepatide to subcutaneous semaglutide prompted this comprehensive research effort

NAION occurs when blood flow to the optic nerve is disturbed or cut off

A spokesperson for Eli Lilly, which produces Zepbound and Mounjaro, told The Independent that Zepbound and Mounjaro autoinjectors and Zepbound vials are approved for single-use onlydose-splitting or microdosing is not contemplated by the FDA-label and may pose patient safety risks. Novo Nordisk, which produces Ozempic and Wegovy, told The Independent the company "[does] not condone the misuse of our products." The company noted it is concerned about non-FDA approved knock-off versions of semaglutide and sources spreading misinformation about GLP-1s to the public. The FDA warns that using unapproved versions of GLP-1 drugs can be risky for patients. This story was updated on September 4, 2025 to include responses from Eli Lilly and Novo Nordisk Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments

Subsequent studies have demonstrated potential anti-inflammatory effects of GLP-1R agonists in both acute and chronic pulmonary disease [5,6]